USPTO serial 97656194
MEDIQUELL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- AREY, BRANDON LEON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDIQUELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David W. Osborne
DAVID W. OSBORNE THORPE NORTH & WESTERN, LLP8180 SOUTH 700 EAST, SUITE 350SANDY, UT 84070UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Oral dosage formulations for use as pharmaceuticals, nutraceuticals, and dietary supplements, taking the form of liquids, syrups, beads, granules, solid tablets, chewable tablets, dissolvable tablets, confections, lozenges, and gum for treatment or prevention of diseases and conditions in the oral cavity, the nasal passages and sinuses, the throat, the respiratory system, the gastrointestinal tract, the endocrine system, the cardiovascular system, the lymphatic system, the nervous system, the skeletal system, the muscular system, the urinary system, or the reproductive system, including symptoms of viral or bacterial infections of the foregoing systems, namely, cough, nasal congestion, runny nose, post-nasal drip, chest congestion, fever, aches, pain, dyspepsia, diarrhea, heartburn, gastroesophageal reflux disease (GERD), and symptoms of autoimmune conditions and disorders, namely, allergies, diabetes, Crohn's disease, fibromyalgia, Addison disease, Celiac disease, and lactose intolerance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 17, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 14, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2022 | NWAP | NEW APPLICATION ENTERED | — |